Portal de Periódicos da CAPES

Previous Antibiotic Exposure and Antimicrobial Resistance in Invasive Pneumococcal Disease: Results From Prospective Surveillance

2014; Oxford University Press; Volume: 59; Issue: 7 Linguagem: Inglês

10.1093/cid/ciu497

1537-6591

Stefan P. Kuster, Wallis Rudnick, Altynay Shigayeva, K. Green, M. Baqi, Wayne L. Gold, Reena Lovinsky, Matthew Muller, Jeff Powis, N.S. Rau, A. E. Simor, Sharon Walmsley, Donald E. Low, Allison McGeer, Simon Allard, I. Armstrong, Barbara Yaffe, David Richardson, D. K. Chen, Michèle C. Health, Rićhard P. Hill, Shelley L. Deeks, Jonathan B. Gubbay, F. Jamieson, H. R. Devlin, Eugenio Villa, Kathleen Dooling, H. Dick, James M. Downey, J. Kapala, Kevin Katz, Ian Kitai, Jennie Johnstone, Sigmund Krajden, Kyoung Suk Lee, Mark Loeb, Fiona Smaill, Marguerite Lovgren, David Rose, Clement Ma, Agron Plevneshi, Barbara Willey, Sylvia Pong-Porter, Ka Sing Wong, Irene Martín, Anne Matlow, S. Richardson, Dat Tran, Shane O’Grady, Kinga Ostrowska, Alicia Sarabia, Joel B. Rodgers, Vicência Sales, Phoebe Shokry, Michael E. Silverman, Mary Vearncombe, Deborah Yamamura,

Emergency and Acute Care Studies

In patients with invasive pneumococcal disease who have been previously exposed to antibiotics, the time elapsed from the end of the most recent treatment course appears to be the most important factor predicting antimicrobial resistance.